Skip to main content
Fig. 1 | BMC Pediatrics

Fig. 1

From: First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery

Fig. 1

Weight (a), serum sodium (b), serum osmolality (c) and urinary output (d) during 10 days of TLV treatment. Responders (red graph) and non-responder (black graph); * p < 0.05 (related to day 0) ** p < 0.01 (related to day 0) *** p < 0.001 (related to day 0). p-values deriving from 2 way ANOVAs; p values for time effect deriving from 2 separate ANOVAS for responders and non-responders. Changes over time regarding bodyweight, serum sodium, osmolality and urinary output have been tested using ANOVAs for repeated measurements with group (responder / non-responder) and time point as fixed factors. The p-values in Table 2 reveal that for each parameter interactions between group and time effects could be observed indicating that response profiles of the two groups differ (see Fig. 1a and d)

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us